AUSTIN, Texas, Apr 04, 2022 (GLOBE NEWSWIRE via COMTEX) — AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT), and Dr. Dilan Ellegala, a member of the Company’s advisory board and co-founder of AfiyaSasa Africa, LLC (“ASA”).
ASA is a medical technology and virtual health company positioned to use artificial intelligence (“AI”) and augmented reality (“AR”) to help meet the needs of patients in developing countries. Through Xcelerate’s 51% interest in ASA, the companies have established a pilot program to implement this technology to improve the healthcare delivery systems for millions of people in Tanzania, Africa.
Speaking with SCV’s Stuart Smith, Dr. Ellegala explains how, during his time in Africa over a decade ago, he identified a massive discrepancy in the number of physicians available for the population. “In my specialty of neurosurgery at the time, there were two neurosurgeons for 44 million people. … the reality is that we could spend 10, 20, 30, 50 years building hospitals clinics, trying to develop health care professionals, spending hundreds of millions, maybe billions of dollars and we probably still wouldn’t meet the basic needs of the population. What I realized is that we needed to leverage the power of advanced technology to try and bridge that gap. It has taken 15-16 years and … we’re finally able, I think, to do this,” he says.
The interview further highlights the application of AI to fill this need, along with Xcelerate’s patent-pending medical surgical device and the Company’s near-term goals.
Listen to the full interview here: https://www.smallcapvoice.com/april-interview-xcelerate-xcrt/.
This news release contains forward-looking statements that reflect Management’s current views about future events and financial performance. Forward-looking statements often contain words such as ”expects,” ”anticipates,” ”intends,” or ”believes.” Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.